Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 7/20 | 0.59 |
| ▸ | CTSK | P43235 | 6/20 | 0.59 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | REN | P00797 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23125787 | 0.88 | CTSS (0.47) | CTSSCTSKACECYP1A2CYP2C9 | |
| SCHEMBL6876021 | 0.88 | ACE (0.63) | CTSSCTSKACECTSLCTSB | |
| SCHEMBL17695878 | 0.88 | ACE (0.63) | CTSSCTSKACECTSLCTSB | |
| SCHEMBL2106430 | 0.88 | ACE (0.63) | CTSSCTSKACECTSLCTSB | |
| SCHEMBL2108340 | 0.84 | CTSS (0.68) | CTSSCTSKACESCN9ACTSL | |
| SCHEMBL2108343 | 0.84 | CTSS (0.68) | CTSSCTSKACESCN9ACTSL | |
| SCHEMBL479103 | 0.83 | CTSS (0.67) | CTSSCTSKACECTSLCTSB | |
| SCHEMBL25382593 | 0.83 | CTSS (0.67) | CTSSCTSKACECTSLCTSB | |
| SCHEMBL479104 | 0.83 | CTSS (0.67) | CTSSCTSKACECTSLCTSB | |
| SCHEMBL479232 | 0.81 | CTSS (0.72) | CTSSCTSKACECTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069602-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | ACONCAGUA BIO INC (US) | 2026-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069602-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | SCTR, SSTR1, NPY1R | CTSS 1117/4885CTSK 1920/4885ACE 926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.